Log in to save to my catalogue

Liver gene therapy by lentiviral vectors reverses anti‐factor IX pre‐existing immunity in haemophili...

Liver gene therapy by lentiviral vectors reverses anti‐factor IX pre‐existing immunity in haemophili...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ebac0ce6ddd046b0865fecd8245a9d7e

Liver gene therapy by lentiviral vectors reverses anti‐factor IX pre‐existing immunity in haemophilic mice

About this item

Full title

Liver gene therapy by lentiviral vectors reverses anti‐factor IX pre‐existing immunity in haemophilic mice

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2013-11, Vol.5 (11), p.1684-1697

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

A major complication of factor replacement therapy for haemophilia is the development of anti‐factor neutralizing antibodies (inhibitors). Here we show that liver gene therapy by lentiviral vectors (LVs) expressing factor IX (FIX) strongly reduces pre‐existing anti‐FIX antibodies and eradicates FIX inhibitors in haemophilia B mice. Concomitantly, p...

Alternative Titles

Full title

Liver gene therapy by lentiviral vectors reverses anti‐factor IX pre‐existing immunity in haemophilic mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ebac0ce6ddd046b0865fecd8245a9d7e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ebac0ce6ddd046b0865fecd8245a9d7e

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.1002/emmm.201302857

How to access this item